MediWound Ltd. — Regulatory Filings 2017

Jul 19, 2017

6-K 1 zk1720272.htm 6-K Licensed to: ZKG Document created using EDGARfilings PROfile 4.3.2.0 Copyright 1995 - 2017 Summit Financial Printing, LLC. All rights reserved.

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549 ____

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934

For the month of July 2017

Commission File Number: 001-36349

MediWound Ltd. (Translation of registrant ’ s name into English)

42 Hayarkon Street

Yavne, 8122745 Israel

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): __

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): __

EXPLANATORY NOTE

On July 19, 2017, MediWound Ltd. issued a press release entitled “ BARDA Upsizes Contract with MediWound and Exercises Option to Fund Further NexoBrid® Indications”. A copy of this press release is attached to this Form 6-K as Exhibit 99.1.

2

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

/s/ Sharon Malka
Name: Sharon Malka
Title: Chief Financial and Operations Officer

3

EXHIBIT INDEX

The following exhibit is filed as part of this Form 6-K:

Exhibit	Description
99.1	Press release dated July 19, 2017 titled “ BARDA Upsizes Contract with MediWound and Exercises Option to Fund Further NexoBrid® Indications ” .

4